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β-glucan
-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced
obese mice
Abstract
© 2020 The Author(s). Background: "Western"style dietary patterns are characterized by a high proportion
of highly processed foods rich in fat and low in fiber. This diet pattern is associated with a myriad of
metabolic dysfunctions, including neuroinflammation and cognitive impairment. β-glucan, the major
soluble fiber in oat and barley grains, is fermented in the lower gastrointestinal tract, potentially impacting
the microbial ecosystem and thus may improve elements of cognition and brain function via the gut-brain
axis. The present study aimed to evaluate the effect of β-glucan on the microbiota gut-brain axis and
cognitive function in an obese mouse model induced by a high-fat and fiber-deficient diet (HFFD). Results:
After long-Term supplementation for 15 weeks, β-glucan prevented HFFD-induced cognitive impairment
assessed behaviorally by object location, novel object recognition, and nesting building tests. In the
hippocampus, β-glucan countered the HFFD-induced microglia activation and its engulfment of synaptic
puncta, and upregulation of proinflammatory cytokine (TNF-α, IL-1β, and IL-6) mRNA expression. Also, in
the hippocampus, β-glucan significantly promoted PTP1B-IRS-pAKT-pGSK3β-pTau signaling for
synaptogenesis, improved the synaptic ultrastructure examined by transmission electron microscopy, and
increased both pre-and postsynaptic protein levels compared to the HFFD-Treated group. In the colon, βglucan reversed HFFD-induced gut barrier dysfunction increased the thickness of colonic mucus (Alcian
blue and mucin-2 glycoprotein immunofluorescence staining), increased the levels of tight junction
proteins occludin and zonula occludens-1, and attenuated bacterial endotoxin translocation. The HFFD
resulted in microbiota alteration, effects abrogated by long-Term β-glucan supplementation, with the βglucan effects on Bacteroidetes and its lower taxa particularly striking. Importantly, the study of shortTerm β-glucan supplementation for 7 days demonstrated pronounced, rapid differentiating microbiota
changes before the cognitive improvement, suggesting the possible causality of gut microbiota profile on
cognition. In support, broad-spectrum antibiotic intervention abrogated β-glucan's effects on improving
cognition, highlighting the role of gut microbiota to mediate cognitive behavior. Conclusion: This study
provides the first evidence that β-glucan improves indices of cognition and brain function with major
beneficial effects all along the gut microbiota-brain axis. Our data suggest that elevating consumption of
β-glucan-rich foods is an easily implementable nutritional strategy to alleviate detrimental features of gutbrain dysregulation and prevent neurodegenerative diseases associated with Westernized dietary
patterns. [MediaObject not available: see fulltext.]
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β-glucan attenuates cognitive impairment
via the gut-brain axis in diet-induced obese
mice
Hongli Shi1, Yinghua Yu1*, Danhong Lin1, Peng Zheng2,3, Peng Zhang1, Minmin Hu1, Qiao Wang1, Wei Pan1,
Xiaoying Yang1, Tao Hu1, Qianqian Li1, Renxian Tang1, Feng Zhou1, Kuiyang Zheng1* and Xu-Feng Huang2,3*

Abstract
Background: “Western” style dietary patterns are characterized by a high proportion of highly processed foods rich in fat
and low in fiber. This diet pattern is associated with a myriad of metabolic dysfunctions, including neuroinflammation and
cognitive impairment. β-glucan, the major soluble fiber in oat and barley grains, is fermented in the lower gastrointestinal
tract, potentially impacting the microbial ecosystem and thus may improve elements of cognition and brain function via
the gut-brain axis. The present study aimed to evaluate the effect of β-glucan on the microbiota gut-brain axis and
cognitive function in an obese mouse model induced by a high-fat and fiber-deficient diet (HFFD).
Results: After long-term supplementation for 15 weeks, β-glucan prevented HFFD-induced cognitive impairment
assessed behaviorally by object location, novel object recognition, and nesting building tests. In the hippocampus, βglucan countered the HFFD-induced microglia activation and its engulfment of synaptic puncta, and upregulation of
proinflammatory cytokine (TNF-α, IL-1β, and IL-6) mRNA expression. Also, in the hippocampus, β-glucan significantly
promoted PTP1B-IRS-pAKT-pGSK3β-pTau signaling for synaptogenesis, improved the synaptic ultrastructure examined by
transmission electron microscopy, and increased both pre- and postsynaptic protein levels compared to the HFFD-treated
group. In the colon, β-glucan reversed HFFD-induced gut barrier dysfunction increased the thickness of colonic mucus
(Alcian blue and mucin-2 glycoprotein immunofluorescence staining), increased the levels of tight junction proteins
occludin and zonula occludens-1, and attenuated bacterial endotoxin translocation. The HFFD resulted in microbiota
alteration, effects abrogated by long-term β-glucan supplementation, with the β-glucan effects on Bacteroidetes and its
lower taxa particularly striking. Importantly, the study of short-term β-glucan supplementation for 7 days demonstrated
pronounced, rapid differentiating microbiota changes before the cognitive improvement, suggesting the possible
causality of gut microbiota profile on cognition. In support, broad-spectrum antibiotic intervention abrogated β-glucan’s
effects on improving cognition, highlighting the role of gut microbiota to mediate cognitive behavior.
(Continued on next page)
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Conclusion: This study provides the first evidence that β-glucan improves indices of cognition and brain function with
major beneficial effects all along the gut microbiota-brain axis. Our data suggest that elevating consumption of β-glucanrich foods is an easily implementable nutritional strategy to alleviate detrimental features of gut-brain dysregulation and
prevent neurodegenerative diseases associated with Westernized dietary patterns.
Keywords: Cognition, Gut microbiota, Gut-brain axis, β-glucan, Obesity

Introduction
Neurodegenerative diseases, such as Alzheimer’s disease
(AD) and related dementias, are a major contributor to
morbidity, drastically impaired quality of life, and health
care costs in an increasingly aging population [1]. These
neurodegenerative diseases are not currently curable;
however, the Lancet commission reported that more
than one-third of dementia cases may be preventable
through addressing lifestyle factors, including diet [1].
Increasing evidence showed that diets can influence the
gut microbiome, potentially modulating brain functions
and subsequent behavior, through the gut-brain axis. For
example, high-fat diet-induced gut microbiota alterations
can induce cognitive impairment in mice [2]. In
addition, obese-type microbiota transplantation has been
shown to disrupt the intestinal barrier and induce a cognitive decline in mice [3]. Furthermore, there is some
evidence that microbial alteration is involved in neuroinflammation and cognitive impairment [3, 4], two important characteristics of AD pathogenesis and progression.
The gut microbiota profile serves as an important
regulator for host intestinal homeostasis and the immune system. It is reported that Ruminococcus of Firmicutes phylum degraded mucus [5], while oral
administration of the human commensal Bacteroides fragilis of Bacteroidetes phylum attenuated intestinal permeability in a mouse model of autism spectrum disorder
[6]. Increased intestinal permeability allows hyper-translocation of bacterial lipopolysaccharide (LPS, endotoxin)
into the blood circulation [2], which can trigger neuroinflammation. Systemic LPS administration activates microglia (principal immune cells in the central nervous system)
and increases the expression of proinflammatory cytokines
in the hippocampus of mice [7]. Proinflammatory cytokines, such as TNF-α, stimulate PTP1B transcription [8],
which inhibits insulin signaling pIRS-pAKT-pGSK3β for
synaptogenesis [9], indicating that PTP1B is an important
mediator between neuroinflammation and synaptic impairment. Research, including from our lab, has shown
that an obesogenic high-fat diet in rodents can lead to increased cytokine production and elevated PTP1B expression in the hippocampus [10, 11], an important brain
region for cognition. It is known that AD patients often
have certain degrees of systemic and neural inflammation,
which may be associated with high-fat and fiber-deficiency

diets [12]. Therefore, the dysregulation of the microbiota
gut-brain axis may induce neuroinflammation, synaptic
impairment, and subsequently cause cognitive decline.
Dietary fiber plays an important role in the proper
functioning of the gut [13]. However, the diets of, for example, Americans, Australians, and Chinese have all experienced a significant decrease in fiber intake over time
[14, 15]. Epidemiological studies have found that dietary
fiber intake is positively associated with cognitive function [16, 17]. While the underlying mechanisms are still
unclear, the gut-brain axis may play an important role.
Soluble dietary fiber β-glucan is fermented in the lower
gastrointestinal tract, potentially resulting in compositional shifts in gut microbiota, such as increased Bacteroidetes and decreased Firmicutes abundances at phylum
level and increased Bacteroides and Prevotella but decreased Dorea at the genus level [18]. Gut microbiota
has been recognized to contribute to host energy metabolism, immunity, or brain health via microbiota metabolites, such as LPS, short-chain fatty acids, amino acids,
and vitamins [4, 19, 20]. The microbial-derived metabolites can be distributed well beyond the gastrointestinal
tract and influence the physiology of the host. Gut
microbiota disturbance can serve as a primary factor to
augment LPS, proinflammatory cytokines, T helper cells,
and monocytes, causing increased intestinal and bloodbrain-barrier permeability. Altered gut microbiota has
been associated with metabolic disorders and neurodegenerative diseases [3, 6]. The accumulative research
data indicate that the manipulation of gut microbiota by
enhancing the proportion of beneficial members of the
community may be a strategy for the regulation of neurotransmitters and prevention or treatment of neurodegenerative diseases [21]. Therefore, β-glucan could have
a strong beneficial effect on improving the gut
microbiota-brain axis altered by Western diet (high-fat
and fiber deficiency), which needs further investigation.
In this study, we used a chronic high-fat and fiberdeficient diet (HFFD), which induced a dysmetabolic
cognitively impaired mouse model. Using this model, we
assessed the effects of long-term β-glucan dietary supplementation on cognitive variables. Cognitive behavior
tests and inflammation and insulin synapse signaling in
the hippocampus, an important brain structure for cognition, were examined along with effects on gut
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microbiota, measures of colonic integrity (colonic mucus
thickness and epithelial tight junction proteins), and
endotoxemia (serum LPS). Furthermore, a short-term
feeding study of β-glucan and, separately, an antibiotic
intervention were used to assess the possibility of a
causal relation between β-glucan-induced gut microbiota
changes and effects on cognition.

Results
Long-term β-glucan supplementation ameliorated
cognitive impairment in HFFD-fed mice

To assess whether long-term β-glucan supplement could
prevent HFFD-induced cognitive impairment, we performed object location, novel object recognition, and
nesting behavioral tests, which explored hippocampusdependent recognition memory and ability to perform
activities of daily living [22–24]. In the object location
test, after 15 weeks of supplementation, β-glucan significantly improved place recognition memory with increasing the place discrimination index (PDI), percentage of
time spent with the object in a novel place in mice compared with the HFFD fed mice (p < 0.05) (Fig. 1a and c).
The difference in PDI of the HFFD and β-glucan mice
was not due to the variant general activity because both
groups had similar total exploration time with the objects during the test phases (p > 0.05) (Fig. 1b). In the
novel object recognition test, the novel object discrimination index (NODI) was significantly decreased in the
HFFD group compared with the control and β-glucan
supplementation group (Fig. 1d and f). The total exploration time of objects during the testing phase was comparable among the three groups (Fig. 1e). In the nesting
behavioral test, the β-glucan group had higher deacon nest
score (ability to build a nest) than that of the HFFD mice
(p < 0.05) without a significant difference to control mice
(Fig. 1d and f). In contrast, the untore nestlet weight
(nest-building deficit) of β-glucan groups was significantly
decreased compared with that of the HFFD group (Fig.
1e). However, the cognition index of the β-glucan group
in object location and nesting behavior tests did not return to the level of the control group. Therefore, the supplementation of β-glucan attenuated the impairment of
cognitive function induced by the HFFD.
Long-term β-glucan supplementation suppressed the
microglia activation and inflammation in the
hippocampus of HFFD-fed mice

Activation of microglia is implicated in neuroinflammation and considered critical in the pathogenesis of neurodegenerative diseases [25, 26]. Western blot analysis
showed β-glucan decreased Iba1 (activation marker of
microglia) level compared with that of the HFFD group
(p < 0.05, Fig. 2a). The morphology of microglia was further investigated by immunofluorescent staining with Iba1
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antibody (Fig. 2b). In the HFFD group, the majority of cells
showed the morphology of activated microglia with elongated soma and fewer branches along CA1, CA3, and DG
of the hippocampus. In the control and β-glucan groups,
the cells showed the characteristic of resting microglia consisting of a rod-shaped cell body with thin processes. We
further determined the spatial location of microglia and
synapses by double immunofluorescent staining of Iba-1
and PSD95 in the three groups (Fig. 2c). PSD95-positive
puncta enveloped by microglia were increased in the HFFD
group compared with control and β-glucan groups, suggesting that β-glucan attenuated the deleterious engulfment
of synapses by activation of microglia seen in HFFD mice.
Furthermore, β-glucan significantly prevented the upregulation of TNF-α, IL-1β, and IL-6 mRNA expression in the
hippocampus (p < 0.05, Fig. 2d–f). These findings indicate
that β-glucan prevented the HFFD-induced activation of
microglia and neuroinflammation and associated deleterious engulfment of synapses.
Long-term β-glucan supplementation improved PTP1BIRS-pAKT-pGSK3β-pTau and synapse in the hippocampus
of HFFD-fed mice

PTP1B is an important mediator cross-linking inflammation and the disruption of insulin signaling IRS-pAKTpGSK3β-pTau for synaptogenesis [8, 9]. Following the
observation of β-glucan amelioration of neuroinflammation, we further evaluated the expression of PTP1B,
pIRS, pAKT, pGSK3β, and pTau in the hippocampus.
With the administration of β-glucan, PTP1B was significantly decreased compared to the HFFD group (p <
0.05), but still higher than the control group (p < 0.05)
(Fig. 3a). β-glucan significantly inhibited the HFFDinduced increase of p-IRS-1 Ser307 (p < 0.05, Fig. 3b),
which is associated with overexpression of PTP1B [27].
Consequently, the insulin signaling downstream molecules, p-Akt Ser473 and p-GSK3β Ser9, were downregulated in the HFFD group, while β-glucan ameliorated
above alterations (all p < 0.05, Fig. 3c and d). Furthermore, β-glucan decreased the level of p-Tau (S202 +
T205) compared with the HFFD group (p < 0.05, Fig.
3e). These results suggest that β-glucan inhibition of
PTP1B may thereafter improve insulin signaling for synaptogenesis and inhibit Tau phosphorylation (a biomarker for Alzheimer’s pathology) in the hippocampus.
There is growing evidence that impaired insulin signaling and Tau over-phosphorylation contribute to synaptic
degeneration [28, 29]. With transmission electron microscopy, the neuronal ultrastructure of synapses in the
CA1 of the hippocampus was examined after long-term
β-glucan consumption. In the HFFD group, presynaptic
terminals were slightly swollen, while the thickness of
the postsynaptic densities was decreased with a widening
of synaptic clefts (Fig. 3f–h). In the β-glucan group, the
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Fig. 1 Long-term β-glucan supplementation ameliorated cognitive impairment in diet-induced obese mice. The object location test was
performed to evaluate the spatial memory of the mice (a–c). a Percentage of time spent with the object in the novel place to total object
exploration time. b The total object exploration time. c Representative track plots of control (Con), HFFD, and HFBG groups recorded by SMART
video tracking system in the testing phase. Note that the control diet-fed mouse spent more time exploring the object in novel place whereas the
HFFD mouse did not show preference to the object in a novel place. The novel object recognition test was performed to evaluate object recognition
memory of the mice (d–f). d Percentage of time spent with the novel object to total object exploration time. e The total object exploration time. f
Representative track plots of control (Con). The nest building test was used to assess the activity of daily living of mice (g–i). g The nest score and h
untore nestler weight (amount of untore nesting material) (n = 15 mice). i Representative nest of control (Con), high-fat and fiber-deficient diet (HFFD),
and β-glucan supplementation in HFFD (HFBG) groups. Values are mean ± SEM. *p < 0.05 vs. Con. #p < 0.05 vs. HFFD

synaptic structure was improved with thicker postsynaptic densities and narrower synaptic clefts compared
with the HFFD group (both p < 0.05, Fig. 3g and h).
Next, we measured two important presynaptic and
postsynaptic proteins, synaptophysin (SYN) and

postsynaptic density 95 (PSD95), by Western blot.
Long-term β-glucan consumption significantly attenuated the decline of both SYN and PSD95 protein
levels compared to the HFFD group (both p < 0.05,
Fig. 3i and j).
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Fig. 2 Long-term β-glucan supplementation suppressed the microglia activation and inflammation in the hippocampus of HFFD-induced obese
mice. a The protein level of Iba1 in the hippocampus (n = 6). b The immunofluorescent staining of Iba1 in CA1, CA3, and DG of the
hippocampus (n = 6) (scale bar 50 μm). The image captured from the box was marked with a dotted line (scale bar 10 μm). c The orthogonal
view of the high-resolution confocal image shows the colocalization of Iba1 (green) and PSD95 (red) (scale bar 5 μm). d–e The mRNA expression
of pro-inflammatory cytokines, TNFα, IL-1β, and IL-6 in the hippocampus (n = 5–6). Values are mean ± SEM. *p < 0.05 vs. control (Con). #p < 0.05
vs. high-fat and fiber-deficient (HFFD)

Long-term β-glucan supplementation prevented colonic
mucosa barrier impairment and inflammation and
ameliorated endotoxemia in HFFD-fed mice

Following β-glucan improving neuroinflammation and
synaptic morphology, we examined the effects of β-glucan
on intestinal barrier integrity. We found that β-glucan increased the thickness of colonic mucus compared with the

HFFD group by using Alcian blue-staining (Fig. 4a and b)
and mucin-2 glycoprotein (MUC2) immunofluorescence
staining in the colon (Fig. 4c). MUC2, a disulfide crosslinked network, expands to form an inner layer which is
rarely colonized by gut microbiota. Figure 4c (the insert)
shows that in the HFFD group luminal bacteria were
closer to the intestinal epithelium suggesting the
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(See figure on previous page.)
Fig. 3 Long-term β-glucan supplementation improved PTP1B-IRS-pAKT-pGSK3β-pTau and synapse in the hippocampus of HFFD-induced obese
mice. a The protein level of PTP1B in the hippocampus (n = 6). b–d Protein levels of p-IRS-1/IRS-1, p-Akt/Akt, and p-GSK3β/GSK3β (n = 6). e The
protein level of p-Tau/Tau in the hippocampus (n = 4–6). f The ultrastructure of synapses on the electron micrograph in the hippocampus CA1
region of mice fed with different diets (scale bar 500 nm). The enlarged images of the second row were from the first row in the area indicated
with a dotted line box (scale bar 250 nm). g and h Image analysis of the thickness of PSD and the width of the synaptic cleft (n = 3). PSD,
postsynaptic density; SC, synaptic cleft; SV, synaptic vesicle. i and j The protein levels of SYN and PSD95. Values are mean ± SEM. *p < 0.05 vs.
control (Con). #p < 0.05 vs. high-fat and fiber-deficient (HFFD)

degradation of the mucus layer by gut microbiota. Fluorescence in situ hybridization (FISH) was used to analyze the
microbiota-epithelial localization in the colon (Fig. 4d). The
distance of microbiota (green) to epithelial cell (blue) was
shorter in the HFFD group, indicating microbiota encroachment, largely reversed by β-glucan with the FISH
examination. The reduction of microbiota encroachment
by β-glucan was accompanied by restoration of the expression of antimicrobial peptide Reg3γ (Fig. 4e), indicating βglucan increases the ability for the mucosa to protect
against bacterial infection. β-glucan increased the levels of
tight junction proteins occludin and zonula occludens-1
(ZO-1) in the colon (both p < 0.05, Fig. 4f). Consequently,
β-glucan consumption attenuated serum LPS levels, which
were elevated by HFFD (Fig. 4g), suggesting β-glucan enhancement of gut barrier integrity attenuated gut permeability to endotoxins. Next, we found that β-glucan
consumption prevented the activation of TNF-α, IL-6, and
IL-1β mRNA expression induced by the HFFD in the colon
tissue (p < 0.05, Fig. 4h). As shortening colon length is associated with inflammation, we further found that β-glucan
ameliorated colon length shortening induced by the HFFD
(p < 0.05, Fig. 4i). Consistent with improved barrier function against endotoxin translocation, serum levels of proinflammatory cytokines were reduced by β-glucan compared
with HFFD (p < 0.05, Fig. 4j). These results indicate that βglucan prevented the damage of intestinal barrier integrity
and the introduction to the circulation of bacterial products
such as LPS, which subsequently promote intestinal and
systemic immune reactions and inflammation.
Long-term β-glucan supplementation prevented gut
microbiota alteration in HFFD-fed mice

To investigate the effects of HFFD, with or without βglucan consumption, on gut microbiota, 16S rRNA gene
sequencing was used to examine the effects of β-glucan
on the diversity and composition of gut microbiota.
HFFD significantly decreased α-diversity in the Shannon
index (6.11 ± 0.13 vs. 5.36 ± 0.16, p = 0.0369). While βglucan consumption (HFBG) and HFFD groups did not
differ in the Shannon index (4.827 ± 0.26 vs. 5.36 ± 0.16,
p = 0.171), principal component analysis (PCoA) of the
UniFrac distance for β-diversity showed a clear separation between the HFFD groups with/without β-glucan
consumption (Fig. 5a). The key phylotypes were

distributed among three bacteria phyla, including Firmicutes, Bacteroidetes, and Proteobacteria (Fig. 5b and c).
HFFD significantly decreased the relative abundance of
Bacteroidetes and increased Proteobacteria compared
with controls (both p < 0.05), while β-glucan restored
these phyla to control group levels. Linear discriminant
analysis effect size (LEfSe) indicated that bacteria belonging to the Bacteroidetes phylum, Bacteroidia class,
Bacteroidales order, S24-7 family were differentially
enriched in gut bacterial communities (LDA score > 3)
between HFBG and HFFD groups (Fig. 5d and e). βglucan supplementation fully prevented the HFFDinduced decrease in the relative abundances of these
bacteria belonging to the Bacteroidetes phylum (Fig. 5f–
i).
KEGG functional orthologs predicted by PICRUSt
identified potential functional interactions between the
gut microbiota and host among dietary groups in level
one KEGG pathways, including cellular process, genetic
information processing, environmental information processing, metabolism, human diseases, and organism system (e.g., environmental adaptation) (Table 1). In level
two KEGG pathways, 8 functional orthologs were significantly altered in the HFFD group when compared with
the control group. Importantly, β-glucan consumption
was associated with marked microbial functional shifts
in 12 functional orthologs, including cell growth and
death, transport, and catabolism, translation in the cellular process; protein folding and associated genetic information processing; signal transduction in environmental
information processing; amino acid, energy, cofactors
and vitamins, and glycan biosynthesis, xenobiotics biodegradation in metabolism; neurodegenerative diseases;
and environmental adaptation.
Short-term β-glucan supplementation prevented HFFDinduced gut microbiota alteration prior to the behavioral
cognitive changes

In order to investigate if β-glucan influences gut microbiota before the cognition changes, HFFD with and
without β-glucan supplementation for 7 days were
assessed. We found that short-term β-glucan supplementation did not change cognitive behavior in HFFD
fed mice (Fig. S2A-D). Furthermore, short-term βglucan supplementation suppressed over intake of
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Fig. 4 Long-term β-glucan supplementation prevented colonic mucosa barrier impairment and inflammation and ameliorated endotoxemia in
HFFD-induced obese mice. a Alcian blue-stained colonic sections were showing the mucus layer (arrows). Opposing black arrows with shafts
delineate the mucus layer that was measured (scale bar 50 μm). b The quantification of the colonic mucus layer was statistically analyzed (per
section/2 sections per animal, n = 5). c Immunofluorescence images of colonic sections stained with Anti-MUC2 antibody and DAPI. Opposing
white arrows with shafts delineate the mucus layer. Inset (HFFD group) shows a higher magnification of bacteria-sized, DAPI-stained particles in
closer proximity to host epithelium and even crossing this barrier. Scale bar 50 μm, inset 10 μm. d FISH analysis of sections of the colon using the
general bacterial probe EUB338-Alexa Fluor 488 (green), and nuclear staining DAPI (blue). Arrows indicate the distance between bacteria and
epithelium. Scale bar 20 μm. e Quantitation of colonic Reg3γ by RT-PCR (n = 6). f Protein levels of occludin and ZO-1 in the colon (n = 5). g
Serum endotoxin level (n = 10). h mRNA expression of TNF-α, IL-1β, and IL-6 in the colon (n = 5). i The quantification of colon length was
statistically analyzed (n = 10) and representative images of colons. j TNF-α, IL-6, and IL-1β levels in the serum (n = 10). Values are mean ± SEM. *p
< 0.05 vs. control (Con). #p < 0.05 vs. high-fat and fiber-deficient diet (HFFD)

energy induced by the HFFD (Fig. S2F) but did not alter
body weight (Fig. S2E). The different effects of shortterm β-glucan supplementation on body weight and food
intake may be due to a time-limit, suggesting that the
consequence of weight change occurs lately but is not
consistent with instant energy intake alteration. However, by 16S rRNA gene sequencing analysis, the PCoA
of the UniFrac distance revealed that HFFD feeding for
7 days dramatically changed gut microbial profile, with
β-glucan-fed mice clustered apart from HFFD-fed mice
sample (Fig. 6a), suggesting quick changes in the gut microbial profile are induced by short-term β-glucan consumption. In line with long-term consumption, shortterm β-glucan consumption significantly increased Bacteroidetes phylum in mice on HFFD (Fig. 6b and c). βglucan also prevented HFFD-increased Firmicutes and
decreased Proteobacteria at phylum. LEfSe analysis
showed that a higher abundance of phylum Bacteroidetes and Proteobacteria and their lower taxonomic level
were notable in the β-glucan group (Fig. 6d), while
phylum Firmicutes and its lower taxonomic levels were
more significantly present in the HFFD group (Fig. S2G).
The PICRUSt analysis showed that a total of 12 functional orthologs may interact between the gut microbiota and host metabolic regulation in the HFFD mice
with short-term β-glucan supplementation (Table S2).
Overall, short-term β-glucan supplementation did not
change body weight and cognition; however, it changed
the gut microbial profile. Therefore, short-term β-glucan
supplementation prevented HFFD-induced gut microbiota alteration prior to the cognitive function and body
weight changes.
Microbiota ablation with antibiotics eliminated the effects
of long-term β-glucan supplementation in abrogating
endotoxemia and cognitive impairment

The above results suggest that the gut microbiota-brain
axis plays an important role in β-glucan in improving
cognition impairment induced by long-term HFFD feeding. To investigate the essential role of gut microbiota in
β-glucan improving cognitive deficits, a cocktail of oral
antibiotics was used to eliminate the β-glucan-induced

gut microbiota effects. We found that the long-term βglucan supplement group with a cocktail of oral antibiotics showed a 20-fold reduction in fecal bacterial load
(Fig. S3). Antibiotics markedly reduced β-glucan promotion of colon length and endotoxemia (Fig. 7a and b).
Furthermore, compared with the HFFD group, antibiotics significantly increased place recognition memory
and novel object recognition memory in the object location and novel object recognition tests (Fig. 7c–f) and
increased deacon nest score and decreased untore nestlet weight in the nest behavior test (Fig. 7g and h). While
compared with the β-glucan supplement group, antibiotics significantly attenuated place and novel object recognition memory (Fig. 7c–f) and decreased deacon nest
score and increased untore nestlet weight in the nest behavior test (Fig. 7g and h). These are all indicative of
cognitive impairment and argue that the gut microbiota
plays an essential role in mediating β-glucan’s positive
impact on both the gut and, through that, on cognition.

Discussion
In the present study, we demonstrated a range of beneficial effects of β-glucan supplementation on the gut
microbiota-brain axis by using a cognitive impairment
mouse model induced by high-fat and fiber-deficient diet
(Fig. 8). For the first time, we present evidence that
long-term β-glucan supplementation ameliorated cognitive impairment assessed behaviorally and at the level of
the hippocampus, and prevented major gut microbiota
shift and mucosal barrier dysfunction assessed with a
broad range of techniques. Furthermore, short-term βglucan supplementation prevented microbial deviation
from the normal state before significant cognitive improvement, suggesting the early response of gut microbiota to β-glucan intake. In addition, by the use of a
broad-spectrum antibiotic intervention, the abrogation
of β-glucan-induced improvement in cognitive function
highlights the essential role of gut microbiota to mediate
cognitive function and behavior.
The microbiota-gut-brain axis is considered to be a
key regulator of neural function. For example,
colonization with a conventional microbiota reverses the
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Fig. 5 Long-term β-glucan supplementation prevented gut microbiota alteration in HFFD-induced obese mice. Cecal contents microbiota
composition was analyzed by 16S rRNA gene sequencing (n = 4–5). a Principal coordinates analysis plot of unweighted UniFrac distances. b
Composition of abundant bacterial phyla. c Comparison of the representative taxonomic abundance among Con, HFFD, and HFBG groups at
phylum. d and e Linear discriminant analysis (LDA) effect size showing the most differentially significant abundant taxa enriched in microbiota
from the Con vs. HFFD as well as HFBG vs. HFFD. f–i Comparison of the representative taxonomic abundance of Bacteroidetes among Con, HFFD,
and HFBG groups at class (g), order (h), family (i), and genus (j). Values are mean ± SEM. *p < 0.05 vs. Control (Con). #p < 0.05 vs. high-fat and
fiber-deficient (HFFD). Abbreviations: p, phylum; c, class; o, order; f, family; g, genus

myelination alteration in germ-free mice both at the
transcriptional and ultrastructural levels [30]. Further,
obese-type microbiota transplantation disrupted intestinal barrier function and induced cognitive decline in
mice [3]. In the present study, we found that long-term

β-glucan consumption ameliorated a shift of gut microbiota composition induced by the HFFD. By using 16S
rRNA gene sequencing analysis, after long-term βglucan supplementation, the abundance of phylum Bacteroidetes was significantly increased, and the abundance
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Table 1 Predicted KEGG functional pathway differences at level 2 inferred from 16S rRNA gene sequences using PICRUSt after
chronic HFFD diet with or without β-glucan supplementation
KO functional categories
Level_1

Level_2

Con mean% HFFD mean% HFBG mean% Con vs HFFD p HFBG vs HFFD
(SD%)
(SD%)
(SD%)
value
p value

Cellular processes

Cell motility

3.491 (0.316)

Cellular processes

Cell growth and death

0.583 (0.013)

0.559 (0.026)

0.596 (0.055)

_

0.019

Cellular processes

Transport and catabolism

0.585 (0.042)

0.419 (0.028)

0.626 (0.065)

0.008

0.016

Genetic information processing

Translation

6.214 (0.205)

5.767 (0.271)

6.503 (0.645)

_

0.032

Genetic information processing

Transcription

3.149 (0.085)

3.526 (0.108)

2.943 (0.388)

0.015

_

Genetic information processing

Folding, sorting, and
degradation

2.675 (0.074)

2.475 (0.157)

2.778 (0.333)

_

0.016

Environmental information
processing

Signal transduction

2.123 (0.083)

2.694 (0.130)

2.000 (0.328)

0.012

0.032

Metabolism

Amino acid metabolism

11.09 (0.226)

10.490 (0.370)

11.311 (0.750)

_

0.032

Metabolism

Energy metabolism

6.565 (0.169)

6.134 (0.325)

6.812 (0.684)

_

0.016

Metabolism

Metabolism of cofactors
and vitamins

4.793 (0.117)

4.618 (0.177)

4.915 (0.404)

_

0.016

Metabolism

Glycan biosynthesis and
metabolism

3.402 (0.204)

2.666 (0.137)

3.592 (0.430)

0.008

0.016

Metabolism

Xenobiotics biodegradation
and metabolism

1.787 (0.051)

1.929 (0.028)

1.724 (0.087)

0.016

0.001

Human diseases

Neurodegenerative diseases

0.175 (0.007)

0.181 (0.008)

0.172 (0.004)

0.027

0.032

4.891 (0.530)

3.084 (1.207)

0.008

_

Organismal systems

Environmental adaptation

0.186 (0.011)

0.218 (0.005)

0.177 (0.015)

0.016

0.032

Cellular processes

Cell motility

3.491 (0.316)

4.891 (0.530)

3.084 (1.207)

0.008

_

Cellular processes

Cell growth and death

0.583 (0.013)

0.559 (0.026)

0.596 (0.055)

_

0.019

Note: Data are given as mean% (SD%). KEGG Kyoto Encyclopedia of Genes and Genomes, PICRUSt Phylogenetic Investigation of Communities by Reconstruction of
Unobserved States, KO KEGG Ortholog, SD standard deviation

of phylum Firmicutes and Proteobacteria were significantly decreased. The further LDA analysis showed that
long-term β-glucan supplementation increased not only
the Bacteroidetes at phylum, but also its lower taxa, such
as Bacteroidia at class, Bacteroidales at order, S24-7 at
family, and Bacteroides at genus in the HFFD-fed mice.
In previous clinical studies, microbiota belonging to
phylum Bacteroidetes has been associated with cognition
and neurodegenerative diseases [31, 32], the corollary
being that infants with high levels of gut Bacteroides at
1 year of age show higher cognitive ability at 2 years of
age [31]. In a cross-sectional study, a lower abundance
of Bacteroides at genus level is reported in the gut
microbiota of dementia patients [32]. At the species
level, Bacteroides fragilis was lower in patients with cognitive impairment [33]. Overall, these findings support
that β-glucan supplementation improves gut microbiota
composition, especially in Bacteroidetes, which may contribute to the prevention of cognition decline in dietinduced obese mice. In addition, the diversity of fecal
microbiota is decreased in AD patients compared to
cognitively healthy controls [34]. We found that gut
microbiota diversity (Shannon index) was reduced in
HFFD mice; however, β-glucan supplementation did not

prevent these alterations in gut microbiota. Therefore, it
is speculative that β-glucan improvement of gut microbiota composition, but not necessarily diversity per se,
may be most critical for improved cognition.
In the present study, β-glucan supplementation for 7
days dramatically increased Bacteroidetes at phylum in
HFFD mice. Similar to the effects during HFFD feeding,
short-term β-glucan supplementation alone increased
Bacteroidetes and decreased Firmicutes (Fig. S4, indicating that the abundance of members of Bacteroidetes is
rapidly driven by the influx of polysaccharide β-glucan
into the large intestine. Bacteroidetes comprise a dominant phylum in the human gut microbiota whose members thrive on dietary polysaccharides by polysaccharide
utilization loci (PUL) [35, 36]. For example, PULs invariably encode a polysaccharide-binding protein at the
outer membrane to capture polysaccharide [35]. Furthermore, PULs encode many polysaccharide lyases and hydrolases, which break down polysaccharide into
oligosaccharide, and also encode transporters at the
inner membrane of Bacteroidetes beneficial for the
uptake of oligosaccharides [36]. Therefore, it is speculative that the host gut symbiont Bacteroidetes facilitate
the acquisition, metabolism, and utilization of
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Fig. 6 Short-term β-glucan supplementation prevented HFFD-induced gut microbiota alteration prior to cognitive improvement. Cecal content
microbiota composition was analyzed by 16S rRNA gene sequencing (n = 5–6) (a–d). a Principal coordinates analysis plot of weighted UniFrac
distances. b Composition of abundant bacterial phyla. c Comparison of the representative taxonomic abundance at phylum. d Linear discriminant
analysis (LDA) effect size showing the most differentially significant abundant taxa enriched in microbiota from the HFBG and HFFD. Values are
mean ± SEM. *p < 0.05 vs. control (Con). #p < 0.05 vs. high-fat and fiber-deficient diet (HFFD). Abbreviations: p, phylum

polysaccharide β-glucan and thereafter to promote the
abundance of Bacteroidetes and its next taxa in gut
microbiota. Overall, these findings suggest that β-glucan
supplementation itself has the ability to prevent HFFDinduced gut microbiota shift (decreased proportion of

Bacteroidetes), rather than body weight manipulation
pushes the microbiota towards a new β-glucan-induced
state.
Synergistically, Bacteroidetes have beneficial effects on
their host intestinal mucosa and barrier function [37].

Fig. 7 Microbiota ablation with antibiotics eliminated the effects of long-term β-glucan supplementation in improving endotoxemia and
cognitive impairment. a The quantification of colon length was statistically analyzed (n = 10). b Serum LPS level (n = 10). *p < 0.05 vs. high-fat
and fiber-deficient diet (HFFD). #p < 0.05 vs. β-glucan (HFBG). c Percentages of time spent with the object in the novel place. d Total object
exploration time. e Percentage of time spent with the novel object. f Total object exploration time. g Nest score. h Untore nesting material (n =
12–15 per group). *p < 0.05. Values are mean ± SEM
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Fig. 8 The interplay between the microbiota and the gut-brain axis in high-fat and fiber-deficient diet (HFFD) and β-glucan intervention. Gut
microbiota contributes to regulating the gut-brain axis and maintaining health, while its alteration (decrease of Bacteroidetes and microbial
diversity) due to HFFD is related to obesity and its adverse consequences on cognition (Steps 1–5). A β-glucan supplementation is thought to
increase Bacteroidetes and gut microbiota (1), thereby, contribute to gut mucus and epithelial integrity and immune homeostasis (2); this
attenuates the translocation of components of Gram-negative bacteria (3), which decreases the peripheral inflammatory tone and inhibits
activation of microglia to neuroinflammation (4) and synapse engulfment in the CNS (5). Therefore, the supplement of β-glucan beneficially
impacts on cognition, via restoration of gut microbiota and its regulatory role in the gut-brain axis

Bacteroides thetaiotaomicron increases colonic gene expression involved in the synthesis of mucosal glycans,
such as α-1,2 fucosyltransferase, α-1,3-fucosyltransferase,
glycosphingolipids, and O-glycans [38]. Oral administration of Bacteroides fragilis strengthen intestinal barrier
and attenuate gut leakage in the autism mouse model
[6]. In the present study, along with an increased abundance of Bacteroidetes, β-glucan prevented HFFDinduced degradation of the colonic mucosal barrier and
microbiota encroachment. Thus, it is speculative that βglucans may serve as platform elements, fermented by
Bacteroidetes, to increase the production of mucosal glycans, thus enhancing the mucus layer overlying the intestinal epithelium to avoid epithelial damage. We
further found that the intestinal tight junction proteins
(occludin and ZO-1) were increased by β-glucan supplementation along with reduced systemic endotoxemia indicating increased integrity of the epithelial barrier and
reduction of translocation of bacterial LPS into the

circulation. Therefore, regular ingestion of β-glucan is
integral to maintaining a healthy balance of microbes
Bacteroidetes for improvement of intestinal integrity and
reduction of intestinal and systemic inflammation in
HFFD-fed mice. Pearson’s correlation analysis showed
that the abundance of Bacteroidetes and its next levels
of microbiota was significantly associated with colon
tight junction proteins, serum LPS, hippocampal proinflammation, and cognitive behavior index (Fig. S5).
Over-exposure of LPS induces microglia activation
and increases proinflammatory cytokines in the hippocampus of mice [7]. It is reported that endotoxin levels
are increased threefold in the blood and two- or threefold in the brain of AD patients [39, 40]. In the present
study, dietary β-glucan constrained microglia activation
and reduced neuroinflammation in the hippocampus.
Therefore, it is speculative that the enhancement of intestinal barrier function and reduction of LPS translocation might then be critical in β-glucan’s beneficial effects
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on the inflammatory cascade in the hippocampus. Proinflammatory cytokines, such as TNF-α, increase PTP1B
transcription [8], block insulin signaling pIRS-pAKTpGSK3β for synaptogenesis [9, 41, 42], and induce Tau
phosphorylation, disrupting synapse formation and
maintenance [29]. We found that long-term β-glucan
supplementation downregulated PTP1B, improved insulin signaling pIRS-pAKT-pGSK3β, and inhibited Tau
over-phosphorylation in the hippocampus. Thus βglucan might exhibit its ability against HFFD-induced
cognitive impairment by lowering neuroinflammation
and restoration of insulin signaling and Tau neuronal
proteins for synaptogenesis.
In our study, we found that the place discrimination
index was decreased in HFFD feeding mice, which is
consistent with other studies demonstrating that cognition was impaired in obese mice [43, 44]. For example,
in Cope’s study, the place discrimination ratio was decreased in obese mice induced by a high-fat diet for 10
weeks compared with the control group, while both
groups had similar total exploration time with the objects during the test phases [44]. Importantly, in our
study, β-glucan supplementation increased place discrimination ratio in object location test compared with
HFFD mice; however, there was no significant difference
in the total exploration time with the objects during the
test phases between two groups. Therefore, the higher
place discrimination index in β-glucan supplementation
group was not due to better general performance, but
increased recognition memory. Furthermore, in this
study, we found that mice on a HFFD built poorer quality nests. It is consistent with the previous study that
high-fat diet-induced obese mice have shown decreased
nest score [45]. We found that β-glucan improved nesting behavior in mice with HFFD feeding. The nesting
behavior test can not only reflect cognition associated
with brain regions in the hippocampus, but also may be
influenced by several factors, such as thermoregulatory
changes and the reduction in activity levels, due to obesity [45].
The dysregulation of synaptic ultrastructure has been
implicated in cognitive impairment and AD [46, 47].
Using transmission electron microscopy, we observed
synaptic structural plasticity and showed a reduction in
PSD thickness and increased the width of the synaptic
cleft in the HFFD group. Presynaptic, SYN, and postsynaptic, PSD95, are important for synaptic plasticity and
synaptogenesis [48]. Reduction in SYN and PSD95 protein levels has been reported in the hippocampus of patients of AD or cognitive impairment [46, 47]. Here,
dietary β-glucan supplementation prevented the reduction of SYN and PSD95 levels in the hippocampus of the
mice with cognitive impairment. Therefore, it is speculative that β-glucan supplementation may contribute to
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the observed improvement in recognition memory and
activities of daily living performance. It is reported that
microglial activation participates in neurodegeneration,
as exemplified by synaptic engulfment and pruning [49].
Here, we found that the HFFD induced a significantly
higher volume of internalized PSD95 in microglia in the
hippocampus than in the β-glucan supplementation
groups again consistent with the β-glucan-induced improvement in synapse integrity and cognitive function.
Antibiotic cocktail treatment is a method that can be
used to explore the effects of the microbiota on physiology and disease in mice [50]. In the previous study, the
effects of antibiotics in control healthy group has been
investigated reporting that antibiotics impair the cognition in control mice (C57 mice) with the disruption of
the gut microbial community [51]. Here, we found that
antibiotics improved cognitive impairment in HFFD
obese mice. It suggests that antibiotics may attenuate
HFFD-induced deleterious gut microbiota for cognition
improvement. Our result is consistent with the previous
study, in which antibiotics improved insulin resistance in
the brain and multiple depressive-like and anxiety-like
behaviors in high-fat diet-induced obese mice [52]. In
contrast to the result of antibiotics in the HFFD group,
we found that antibiotics abrogated β-glucan-induced
improvement in cognitive function. These findings of
antibiotic intervention suggest that gut microbiota regulated by β-glucan play an important role in cognition, rather than antibiotics directly affect the observed
cognitive phenotypes.
β-glucans can be from various sources, which can have
different chemical structures and vary in function. The
β-glucans in cereal such as oat and barley are primarily
in β(1,4) linkages separating shorter stretches of β(1,3)
structure. While bacterial β-glucans consist of linear β(1,
3) linkages, the β-glucans of mushrooms and fungi have
a β(1,3) backbone branched with short β(1,6)-linked side
chains. The cereal mixed-linkage β(1,3)/β(1,4)-glucan
(MLG) is the specific site of hydrolysis by the MLG
Utilization Locus (MLGUL), BoGH16MLG of Bacteroidetes lower taxa, such as Bacteroides ovatus [35]. Therefore, β(1,4)/β(1,3)-glucan is mainly fermented by gut
microbiota in the lower gastrointestinal tract, potentially
resulting in compositional and functional shifts in the
gut microbiota [18, 53]. While only β(1,3) stimulates immunity and allows β(1,3) or β(1,3)/β(1,6)-glucans are
recognized by dectin-1 and toll-like receptor-2 in various
cells [54], it was reported that β-glucans from bacteria,
mushroom, or fungi evoke the activation of immune
cells and trigger the inflammatory response, such as activation of NF-κB [55]. In addition, low dose fungal βglucan has been reported to promote highly immunoregulatory activity (FoxP3) and induce anti-inflammatory
cytokines, including IL-10, TGFβ, and IL-2 via dectin-1
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[56]. β(1,4)/β(1,3)-glucan is derived from oat or barley,
which are common dietary fibers consumed in our daily
life. In the present study, we investigated the effects of
oral supplementation of β(1,4)/β(1,3)-glucan derived
from oat on the gut microbiota and gut-brain axis to reduce neuroinflammation in the hippocampus of HFFD
mice. However, it is unknown if oat β(1,4)/β(1,3)-glucans
have direct effects on the immune cell, which requires
further investigation.
Our previous studies have shown that oat β-glucans
increase colon L cell-derived satiety hormone peptide YY (PYY) in the clinical and rodent studies [57, 58]. It is
reported that microbiota or its metabolites are associated with L cell activity and PYY secretion. For example,
the abundance of A. muciniphila is associated with
higher L cell number and activity [59]. Short-chain fatty
acids, produced at high levels through the fermentation
of fiber (such as β-glucan) by gut microbiota, potently
stimulate PYY production in human enteroendocrine
cells [60]. Previously, we found that oat β-glucans increase satiety by activation of the gut-hypothalamic
(PYY-NPY) axis in diet-induced obesity in mice [61].
Therefore, these findings suggest that β-glucan as prebiotics can activate the gut-brain axis to increase satiety
and reduce energy intake. Excessive dietary energy intake and insulin resistance have adverse effects on cognition reported in humans and rodent studies; however,
energy restriction enhances neural plasticity by decreased inflammation and increased expression of synaptic plasticity-associated proteins [62]. Indeed, we found
that the amount of energy intake on long-term β-glucan
supplementation was negatively correlated with adverse
metabolic parameters and positively correlated with cognitive parameters (Table S3). Therefore, the reduction of
energy intake and improvement of metabolic parameters
by β-glucan may contribute to cognition improvement.
β-glucan supplementation not only regulates satiety via
the gut-hypothalamic (PYY-NPY) axis. In the present
study, we also found that oat β-glucan supplementation
attenuated alterations caused by HFFD, including gut
microbiota shift, gut barrier disruption, hippocampal inflammation, and abnormal synaptic ultrastructure.
Therefore, β-glucan supplementation in maintaining the
gut microbiota-brain (hippocampus) axis is important to
prevent cognition decline induced by HFFD.

Conclusions
The current results provide consistent evidence linking
increased β-glucan intake to improved gut microbiota
profile, intestinal barrier function, reduced endotoxemia,
and enhanced cognitive function via more optimized
synaptic and signaling pathways in critical brain areas.
The use of an antibiotic intervention to abrogate the
beneficial effects of β-glucan supplementation on gut
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microbiota also prevented the beneficial effect on cognitive impairment, suggesting the relationship between gut
microbiota alteration and cognitive impairment may be
causal. In addition to highlighting the adverse impact of
Western diets on the gut-brain axis, the findings of this
study suggest enhanced consumption of β-glucan-rich
foods is an easily implementable nutritional strategy to
attenuate the diet-induced cognitive decline.

Methods
Animals

C57BL/6 J male mice (11 weeks old) were obtained from
the Experimental Animal Center of Xuzhou Medical
University (SCXK_Su_2015-0009), and housed in environmentally controlled conditions (temperature 22 °C, 12
h light/dark cycle). After acclimatization to the laboratory conditions for 1 week, the mice were used for experiments in accordance with the Chinese Council on
Animal Care Guidelines and approved by Institutional
Animal Care Committee of Xuzhou Medical University.
Long-term β-glucan supplementation experiment and
cocktail antibiotic administration

The mice were randomly divided into 3 groups (n = 15
per group): (1) the control (Con) group were fed a grainbased rodent lab chow (LC, LabDiet 5010, 13.1% fat by energy, 15% neutral detergent fiber by weight), (2) the HFFD
group were fed with a diet with high fat (55% by energy)
and fiber deficient (50 g/kg from cellulose, low accessibility by gut microbiota, 5% fiber by weight); (3) the β-glucan
(HFBG) group were fed with oat β-glucan derived from
OatWellTM oat bran (CreaNutrition, Switzerland) added
into the HFFD (β-glucan 7% by weight, fiber content 14%
by weight, detailed in Table S1). The dosage was according to our previous study [57] in which 7% oat β-glucan
improved the regulation of the gut-hypothalamic
(PYY3-36-Y2-NPY) axis. In addition, a fourth group
(HFBG+AB, n = 12) was run in parallel with antibiotics
(ampicillin 1 g/L, vancomycin 0.25 g/L, neomycin 1 g/L,
and metronidazole 1 g/L) added to their drinking water
with water renewed every 3 days for 15 weeks [63]. Mice
fed a HFFD showed increased body weight from week 4
onwards, increased body fat accumulation and liver
weight, and glucose intolerance (Fig. S1A-E). β-glucan
supplementation attenuated these metabolic disturbances,
but the final body weight and epididymal fat mass of the
β-glucan supplement group were still higher than that of
the control group. The lower body weight and improvement of other metabolic parameters may be due to the decreased energy intake by β-glucan supplements. The
positive correlation was found between energy intake and
body weight and other metabolic parameters (Supplement
Table 3). Three cognitive behavior tests were performed
after 15 weeks of intervention (described below). Three
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days following the last test, nine mice per group were
sacrificed using CO2 asphyxiation. Blood, cecum content,
colon, liver, fat (epididymal, inguinal, and interscapular
masses), and brain tissues were immediately collected for
the investigations of mRNA (left hippocampus) and protein expression (right hippocampus). The remaining mice
(n = 6 per group) were sacrificed by CO2 asphyxiation and
then transcardially perfused with PBS and paraformaldehyde for the studies of hippocampal immunohistochemistry and electron microscopy.
Short-term β-glucan supplementation experiment

Similar to the long-term β-glucan supplementation experiment, the mice were randomly divided into three
groups (n = 10 per group): the Con group, HFFD group,
and HFBG group were respectively fed with the LC diet,
HFFD, and 7% oat β-glucan in the HFFD for 7 days.
After performing two cognitive behavior tests, the mice
were sacrificed with a collection of cecum content for
16S rRNA gene sequencing of gut microbiota.
The long-term and short term β-glucan supplementation was repeated with 2 independent cohorts of mice.
Behavioral tests

The object location, novel object recognition, and nesting behavior tests were performed in order to examine
dietary effects on recognition memory and spontaneous
rodent behaviors. Tests were conducted similar to previous studies [22, 24]. In the object location test, the place
discrimination index (PDI) was calculated by using the
formula: the time spent with the object moved to a novel
place/the total time spent in exploring both the object
moved to a novel place and the object remaining in the
familiar place × 100. In the novel object recognition test,
the novel object discrimination index (NODI) was calculated by using the formula: the time spent with the novel
object/the total object exploration time × 100. For the
nesting behavior test, the Deacon nest score and the
untore nestlet weight were used to evaluate spontaneous
rodent behavior (the ability of daily living).
Microbial DNA extraction, PCR amplification, and Miseq
sequencing in cecal contents

Genomic DNA amplification and sequencing were conducted as in our previous study [2]. Briefly, microbial
DNA was extracted from the cecal contents of mice
using the E.Z.N.A. stool DNA Kit (Omega Bio-tek, Norcross, GA, U.S.) according to the manufacturer’s protocols. The 16S rDNA V3-V4 region of the eukaryotic
ribosomal RNA gene was amplified by PCR (95 °C for 2
min, followed by 27 cycles at 98 °C for 10 s, 62 °C for 30
s, and 68 °C for 30 s; and a final extension at 68 °C for
10 min) using primers 341F: CCTACGGGNGGCWGCA
G; 806R: GGACTACHVGGGTATCTAAT, where the
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barcode is an eight-base sequence unique to each sample. PCR reactions were performed in triplicate 50 μL
mixture containing 5 μL of 10 × KOD Buffer, 5 μL of
2.5 mM dNTPs, 1.5 μL of each primer (5 μM), 1 μL of
KOD polymerase, and 100 ng of template DNA Amplicons extracted from 2% agarose gels and purified using
the AxyPrep DNA Gel Extraction Kit (Axygen Biosciences, Union City, CA, USA) according to the manufacturer’s instructions and quantified using QuantiFluor-ST
(Promega, USA). Purified amplicons were pooled in
equivalent molar and paired-end sequences (2 × 250) on
an Illumina platform according to the standard
protocols.
Measurement of serum cytokines

ELISA kits were used to measure TNF-α, IL-6, and IL1β of serum according to the manufacturer’s instructions
(Thermo Fisher, USA).
Lipopolysaccharide determination

The concentration of circulating serum LPS was measured by enzyme-linked immunosorbent assay (Limulus
assay kit, Cat.18110115, China). The absorbance was
measured at 545 nm using a spectrophotometer, with
measurable concentrations ranging from 0.1 to 1.0 EU/
ml. All samples for LPS measurements were performed
in duplicate.
Intraperitoneal glucose tolerance test

The intraperitoneal glucose tolerance test (IPGTT) was
conducted as we have previously described [64]. Briefly,
mice were fasted overnight followed by an intraperitoneal injection of glucose (2 g/kg). Blood samples were
obtained from the tail vein at 0, 30, 60, 90, and 120 min
following the injection of glucose. Blood glucose levels
were measured with a glucose meter (Accu-Chek).
Thickness measurements of the colonic mucus layer

Post Carnoy’s fixation, the methanol-stored colon samples were embedded in paraffin, cut into thin sections
(5 μm), and deposited on glass slides. Alcian blue staining was performed by the protocols as previously published [65]. The thickness of the colonic sections was
then measured (10 measurements per section/2 sections
per animal/5 animals per group) using ImageJ after
cross-validation using anti-MUC2 staining.
Bacteria localization by FISH staining

The staining of bacteria localization at the surface of the
intestinal mucosa was conducted as previously described
[66]. Briefly, transverse colonic tissues full of fecal material were placed in methanol-Carnoy’s fixative solution
(60% methanol, 30% chloroform, 10% glacial acetic acid)
for a minimum of 3 h at room temperature. Tissues were
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then washed in methanol 2× 30 min, ethanol 2× 20 min,
and xylene 2× 20 min, and embedded in paraffin for 5μm sections on glass slides. The tissue sections were
dewaxed by preheating at 60 °C for 10 min, followed by
xylene 60 °C for 10 min, xylene for 10 min, and 100%
ethanol for 10 min. Deparaffinized sections were incubated at 37 °C overnight with EUB338 probe (5′-GCTG
CCTCCCGTAGGAGT-3′) diluted to 10 μg/mL in
hybridization buffer (20 mM Tris–HCl, pH 7.4, 0.9 M
NaCl, 0.1% SDS, 20% formamide). After incubating with
wash buffer (20 mM Tris–HCl, pH 7.4, 0.9 M NaCl) for
10 min and 3× 10 min in PBS sequentially, the slides
were mounted in DAPI-containing mounting medium.

internal reference control. Primer sequences were as follows: mTNFα--forward (F): CTTGTTGCCTCCTCTT
TTGCTTA, mTNFα--reverse (R): CTTTATTTCT
CTCAATGACCCGTAG;
mIL-1β--forward
(F):
TGGGAAACAACAGTGGTCAGG,
mIL-1β--reverse
(R): CTGCTCATTCACGAAAAGGGA; mIL-6--forward
(F): TCACAGAAGGAGTGGCTAAGGACC, mIL-6--reverse
(R):
ACGCACTAGGTTTGCCGAGTAGAT;
mGAPDH--forward (F): AGAAGGTGGTGAAGCAGG
CATC, mGAPDH--reverse (R): CGAAGGTGGAAGAG
TGGGAGTTG;
mReg3γ--forward
(F):
5′
TTCCTGTCCTCCATGATCAAA-3′, mReg3γ--reverse
(R): 5′CATCCACCTCTGTTGGGTTC-3.

Immunohistochemistry

Western blotting

MUC2 in the colon was detected by staining the colonic
tissue sections (5 μm) with anti-MUC2 antibody (Abclonal, A14659) diluted 1:500 in TBS and goat-anti-rabbit
Alexa 488 conjugated antibody (1:1000) (Invitrogen,
A32731) in TBS. At a temperature of − 18 °C, 20 μm frozen brain sections (hippocampus) were cut using a cryostat from Bregma − 3.3 to − 4.16 mm according to a
standard mouse brain atlas [67]. The brain slices were
blocked with 10% goat normal serum for 15 min at room
temperature and then incubated with the primary antibodies at 4 °C overnight. The primary antibody anti-Iba1
(Wako, 019–19741) and PSD95 (CST, 3450) were used.
After washing with PBS, the sections were incubated
with the secondary antibodies at 37 °C for 1 h. The secondary antibody Alexa Fluor® 594 (abcom 150160) and
Alexa Fluor® 488 (ab150117) were used. Finally, the sections were counterstained with DAPI (Sigma, D9542).
The morphology of microglia in the CA1, CA3, and DG
of the hippocampus was then imaged with a microscope
(OLYMPUS IX51). The hippocampal CA1 area in brain
tissue sections was imaged by a Leica SP8 confocal
microscope system equipped with a × 63 oil immersion
objective (Leica, Germany) by using identical light intensity and exposure settings in stacks (z-step 0.1 μm). The
images of contact between microglia and postsynaptic
structures in identical × 60 image stacks from sections
double-labeled for Iba1 and PSD95 were processed by
the LAS X software (Leica, Germany).

Mouse colon and hippocampus were homogenized in
ice-cold RIPA lysis buffer, supplemented with complete
EDTA-free protease inhibitor cocktail and PhosSTOP
Phosphatase Inhibitor. The homogenate was sonicated
six times for 4 s, at 6 s intervals on ice and then centrifuged at 12,000 g for 20 min at 4 °C. The supernatant
was collected, and the protein concentration was quantitated by BCA assay. Equal amounts of protein were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes. The membrane was blocked with 5% non-fat milk at room
temperature for 1 h, and then incubated with the primary antibody at 4 °C overnight. These primary antibodies were included: anti-occludin (Abcam, ab167161),
anti-ZO1 (Abcam, ab96587), anti-p-IRS-1 (Ser307)
(CST, 2381T), anti-IRS-1 (CST, 2382S), anti-Iba1
(Wako, 019–19741), anti-p-GSK-3β(Ser9) (CST, 9322S),
anti-GSK-3-β (CST, 12456T), anti-p-AKT(Ser473) (CST,
4060T), anti-AKT (CST, 4691T), anti-Tau5 (Abcam,
ab80579), anti-p-Tau (S202 + T205) (Abcam, ab80579),
anti-synaptophysin (Abcam, ab32127), anti-PSD95 (CST,
3450), anti-PTP1B (Abcam, ab189179), GAPDH (ABclonal, AC033), and β-actin (ABclonal, AC026). Following 3
washes in TBST, the membrane was incubated with
HRP-inked anti-rabbit IgG secondary antibody (CST,
7074) or HRP-linked anti-mouse IgG secondary antibody
(CST, 7076S) at room temperature for 1 h. After washing
3 times with TBST, the protein bands were detected
with Clarity™ ECL western blot substrate (Bio-Rad, 1,
705,060) and visualized using the ChemiDoc Touch imaging system (Bio-Rad).

Quantitative RT-PCR

Total RNA was extracted from tissues homogenized in
Trizol (Thermo Fisher Scientific, Waltham, MA, USA).
One microgram of purified RNA was used for RT-PCR
to generate cDNA with a High-Capacity cDNA Reverse
Transcription Kit (Takara, Dalian, China), and the
resulting cDNA was used for quantitative PCR on a realtime PCR detection system (Bio-Rad, Hercules, CA,
USA). The relative mRNA expression level was determined with the 2-ΔΔCt method with GAPDH as the

Transmission electron microscopy

The left side of the hippocampal CA1 was taken and
rapidly fixed in glutaraldehyde. After fixation for 24 h,
the hippocampal tissues of control, HFFD, and HFBG
mice were quickly dissected and separated into thin
slices. They were fixed immediately with 2.5%

Shi et al. Microbiome

(2020) 8:143

Page 19 of 21

glutaraldehyde at 4 °C overnight. Washed 3 times in
phosphate-buffered saline (PBS), these slices were fixed
in 1% osmium tetroxide, stained with 2% aqueous solution of uranyl acetate, and then dehydrated with different concentrations of ethanol and acetone gradient.
Finally, they were embedded in epoxy resin. Ultra-thin
sections (70 nm) were cut with ultramicrotome, collected
on copper grids, and then stained with 4% uranyl acetate
and lead citrate. Synapses are classified into asymmetric
and symmetric synapses, or Gray I type and Gray II type
synapses, which are considered to mediate excitatory
and inhibitory transmission, respectively. Asymmetric
synapses have prominent postsynaptic densities and relatively wide synaptic clefts while symmetric synapses are
with pre- and postsynaptic densities of equal thickness
and narrower synaptic clefts. In the present study, asymmetric synapses were examined for excitatory synaptic
measurement. The PSD thickness was evaluated as the
length of a perpendicular line traced from the postsynaptic membrane to the most convex part of the synaptic
complex. The widths of the synaptic clefts (SCs) were estimated by measuring the widest and narrowest portions
of the synapse and then averaging these values.

attenuated by long-term β-glucan supplementation. (A) Body weight
over time (n=15). (B) Average energy intake (n=15). (C) Fat pad weight
(n=9). (D) liver mass (n=9) and representative images of livers. (E) Glucose
tolerance test and area under curve (AUC) calculated (n=10). Values are
mean ± SEM. *p < 0.05 vs. Con. #p < 0.05 vs. HFFD. $p <0.05 vs. Con.
eWAT: epididymal white adipose tissue; iWAT: inguinal white adipose tissue; iBAT: interscapular brown adipose tissue. Figure S2. Short-term βglucan (HFBG) supplementation for 7 days did not affect body weight
and cognitive behaviours in mice. (A) Percentages of time spent with the
object in the novel place to total object exploration time. (B) Total object
exploration time. (C) Nest score. (D) Untore nestler weight (amount of
untore nesting material). (E) Body weight. (F) Average energy intake. (G)
Linear discriminant analysis (LDA) effect size showing the most differentially significant abundant taxa enriched in microbiota from the control
(Con) vs. HFFD. *p < 0.05 vs. Control (Con). #P < 0.05 vs. high-fat and
fibre-deficient (HFFD). Figure S3. Antibiotics significantly decreased bacterial DNA of faces in HFBG mice (n = 6). *p < 0.05 β-glucan supplementation in HFFD (HFBG) group vs. β-glucan supplement with antibiotics
(HFBG+AB) group. Figure S4. Short-term β-glucan supplementation (BG)
alone affected the gut microbiota. Caecal contents microbiota composition was analyzed by 16S rRNA gene sequencing (n=5-6). β-glucan supplementation increased Bacteroidetes and decreased Firmicutes (A).
Principal coordinates analysis plot of weighted UniFrac distances (B). *p <
0.05 vs. Control (Con). Figure S5. Pearson’s correlations between Bacteroidetes and its down taxa, and the parameters of gut, brain and cognitive
behaviour. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Statistical analysis

Additional file 4: Table S3. Pearson correlations between energy
intake and metabolic and behavior parameters.

Data were analyzed using the statistical package SPSS
(Version 20, Chicago, USA). After data were tested for
normality, the differences among the intervention groups
were determined using a one way analysis of variance
(ANOVA) followed by the post hoc Tukey-Kramer test.
A p value of < 0.05 was considered to be statistically significant. For 16S rRNA gene sequencing analysis, all
reads were deposited and grouped into operational taxonomic units (OTU) at a sequence identity of 97%, and
the taxonomic affiliation of the OTUs was determined
with quantitative insights into microbial ecology
(QIIME, version 1.8.0) against the Greengenes database
version 13.8. Based on the Kyoto Encyclopedia of Genes
and Genomes (KEGG) functional pathway, the predicted
functional composition of the intestinal microbiome was
inferred for each sample using Phylogenetic Investigation of Communities by Reconstruction of Unobserved
States (PICRUSt) [68]. Statistical analyses were conducted with STAMP, and functional differences in
orthologs among groups were assessed by a one way
ANOVA followed by post hoc Tukey-Kramer multiple
comparisons.

Additional file 2: Table S1. Composition of the diets including βglucan derived from oat bran ingredient
Additional file 3: Table S2. Predicted KEGG functional pathway
differences at level 2 inferred from 16S rRNA gene sequences using
PICRUSt after acute HFFD diet with or without β-glucan supplementation.
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